Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Microbiology, Diagnostic Services of Manitoba, Winnipeg, MB, Canada.
J Med Microbiol. 2012 Sep;61(Pt 9):1306-1310. doi: 10.1099/jmm.0.042333-0. Epub 2012 Jun 14.
The purpose of this study was to determine optimal criteria for microbiology laboratory screening of endotracheal tube (ETT) specimens submitted for bacterial culture from adult patients. ETT specimens from adult patients that were received by two microbiology laboratories were prospectively evaluated and subdivided into one of three study arms with the following criteria: <10 squamous epithelial cells (SECs) per low-power field with bacteria seen on Gram staining (arm 1), >10 SECs per low-power field with bacteria seen on Gram staining (arm 2) and <10 SECs per low-power field with no bacteria seen on Gram staining (arm 3). A fourth study arm (>10 SECs per low-power field with no bacteria seen on Gram staining) was planned but this arm was terminated due to the paucity of specimens meeting these criteria. Isolate evaluation was performed using standard microbiology protocols. A limited chart review was undertaken at one of the institutions, only reviewing patients from which a potential pathogen was recovered on culture. In total, 141 ETT specimens were evaluated. A potential respiratory pathogen was recovered from 54, 37 and 10 % of specimens in study arms 1, 2, and 3, respectively (P<0.0001, comparing between arm 1 and arm 3). For the 23 patients included in the chart review from whom a potential pathogen was recovered on culture, respiratory infection was considered to be present in 50 % (6/12) of patients in arm 1, 66.6 % (6/9) of patients in arm 2 and 100 % (2/2) of patients in arm 3. Therapy was rarely altered based on culture results. In this study, the ETT specimens submitted for bacterial culture were of limited benefit to clinicians. The data presented here support the use of an absence of bacteria on Gram staining as a rejection criterion for ETT specimens. The criterion of >10 SECs per low-power field should be further evaluated in a prospective study of patients with an unequivocal clinical diagnosis of pneumonia.
这项研究的目的是确定用于微生物实验室筛选成人患者提交的用于细菌培养的气管内导管(ETT)标本的最佳标准。通过两个微生物实验室前瞻性评估并细分成年患者的 ETT 标本为以下三个研究组之一,具有以下标准:低倍镜视野下每 10 个鳞状上皮细胞(SEC)中少于 10 个有细菌,革兰氏染色可见(组 1);低倍镜视野下每 10 个 SEC 中有超过 10 个有细菌,革兰氏染色可见(组 2)和低倍镜视野下每 10 个 SEC 中有少于 10 个有细菌,革兰氏染色不可见(组 3)。计划了第四个研究组(低倍镜视野下每 10 个 SEC 中有超过 10 个有细菌,革兰氏染色不可见),但由于符合这些标准的标本数量很少,该组被终止。使用标准微生物学方案进行分离物评估。在其中一个机构进行了有限的图表审查,仅审查从培养中回收潜在病原体的患者。总共评估了 141 个 ETT 标本。在研究组 1、2 和 3 中,分别从 54%、37%和 10%的标本中回收了潜在的呼吸道病原体(P<0.0001,组 1 与组 3 之间比较)。在从培养中回收潜在病原体的 23 名图表审查患者中,有 50%(6/12)的患者在组 1、66.6%(6/9)的患者在组 2和 100%(2/2)的患者在组 3 中存在呼吸道感染。根据培养结果很少改变治疗。在这项研究中,提交用于细菌培养的 ETT 标本对临床医生的帮助有限。这里提供的数据支持将革兰氏染色无细菌作为气管内导管标本的拒收标准。应在一项针对具有明确肺炎临床诊断的患者的前瞻性研究中进一步评估每低倍镜视野下超过 10 个 SEC 的标准。